
THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION
Publication
, Conference
Gibson, CM; Yee, M; Daaboul, Y; Korjian, S; Mehr, AP; Kerneis, M; Tricoci, P; Alexander, J; Kastelein, J; Mehran, R; Bode, C; Lewis, B ...
Published in: Journal of the American College of Cardiology
March 2018
Duke Scholars
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2018
Volume
71
Issue
11
Start / End Page
A165 / A165
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Gibson, C. M., Yee, M., Daaboul, Y., Korjian, S., Mehr, A. P., Kerneis, M., … Merkely, B. (2018). THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION. In Journal of the American College of Cardiology (Vol. 71, pp. A165–A165). Elsevier BV. https://doi.org/10.1016/s0735-1097(18)30706-x
Gibson, C Michael, Megan Yee, Yazan Daaboul, Serge Korjian, Ali Poyan Mehr, Mathieu Kerneis, Pierluigi Tricoci, et al. “THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION.” In Journal of the American College of Cardiology, 71:A165–A165. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)30706-x.
Gibson CM, Yee M, Daaboul Y, Korjian S, Mehr AP, Kerneis M, et al. THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION. In: Journal of the American College of Cardiology. Elsevier BV; 2018. p. A165–A165.
Gibson, C. Michael, et al. “THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION.” Journal of the American College of Cardiology, vol. 71, no. 11, Elsevier BV, 2018, pp. A165–A165. Crossref, doi:10.1016/s0735-1097(18)30706-x.
Gibson CM, Yee M, Daaboul Y, Korjian S, Mehr AP, Kerneis M, Tricoci P, Alexander J, Kastelein J, Mehran R, Bode C, Lewis B, Mehta R, Duffy D, Feaster J, Halabi M, Angiolillo D, Duerschmied D, Ophius TO, Merkely B. THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. Elsevier BV; 2018. p. A165–A165.

Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2018
Volume
71
Issue
11
Start / End Page
A165 / A165
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology